BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1649 related articles for article (PubMed ID: 28223375)

  • 1. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 2. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Bouza E; Guinea J
    J Antimicrob Chemother; 2017 Jul; 72(7):1969-1976. PubMed ID: 28175309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
    Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
    Dekkerová J; Lopez-Ribot JL; Bujdáková H
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Berkow EL; Angulo D; Lockhart SR
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483955
    [No Abstract]   [Full Text] [Related]  

  • 7. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 9. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.
    Moreira A; Silva S; Botelho C; Sampaio P; Pais C; Henriques M
    Mycopathologia; 2015 Dec; 180(5-6):305-15. PubMed ID: 26179982
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract.
    Sharifzadeh A; Soltani M; Shokri H
    Mycoses; 2015 Aug; 58(8):478-84. PubMed ID: 26152466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilm formation by Candida auris isolated from colonising sites and candidemia cases.
    Singh R; Kaur M; Chakrabarti A; Shankarnarayan SA; Rudramurthy SM
    Mycoses; 2019 Aug; 62(8):706-709. PubMed ID: 31132181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    Srivastava V; Ahmad A
    PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
    Sherry L; Ramage G; Kean R; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R
    Emerg Infect Dis; 2017 Feb; 23(2):328-331. PubMed ID: 28098553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
    J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.